Results for "Guidewire Software"

Insurance technology firm Guidewire reported Non-GAAP EPS of $0.99 and revenue of $411.0M, outperforming analyst projections thanks to strong subscription renewals and new deployments.

Guggenheim Securities has raised its price targets for Amylyx Pharmaceuticals, Salesforce, and Guidewire Software, highlighting positive developments in clinical trials, AI integration, and recurring revenue outlooks. The adjustments signal improved analyst sentiment across healthcare, enterprise software, and insurance tech sectors.

Guidewire Software is reportedly enhancing its profitability through the strategic implementation of internal AI efficiency measures.

Guidewire Software (GWRE) experienced pressures from the broader software industry, which impacted its performance in the first quarter.

Guidewire Software Inc. has announced the launch of its new ProNavigator AI Assistant, integrated into its Palisades Release, aiming to enhance workflows and capabilities for its users.

Guidewire Software (GWRE) experienced a decrease in its stock value, trading lower in line with its industry peers.

Analysts express skepticism towards nCino and caution on Guidewire Software, citing broader headwinds affecting the software sector.

U.S. equity index futures posted modest gains in early trading, though shares of Lululemon and Guidewire Software faced downward pressure ahead of market open.

Market analysts outline key metrics and expectations ahead of Guidewire Software's fourth quarter 2026 earnings release.

Senior executives and board members at several publicly traded companies, including Deere, Charles Schwab, and Pinterest, have filed disclosures for routine stock sales totaling millions of dollars. The transactions follow standard pre-arranged trading plans and do not necessarily signal broader market sentiment.

Guidewire Software (GWRE) is reported to remain well-positioned in the market, even amidst broader concerns about AI growth.

Guidewire Software has shared highlights from its third quarter earnings call, outlining its financial performance and business progress.

Investment banks have issued updated price targets for several companies, including a trim for Guidewire Software by Citi and raises for Oruka Therapeutics by Wedbush, and Halliburton and Noble Corp. by Citi. These adjustments reflect revised market valuations and outlooks across different sectors.

Guidewire Software has released highlights from its second-quarter earnings call, providing an overview of its financial performance and business updates.

Several publicly traded companies, including Lululemon, Zscaler, and Guidewire Software, experienced notable price swings in extended trading sessions following recent corporate developments.

Guggenheim Securities has raised its price targets for Amylyx Pharmaceuticals, Salesforce, Guidewire Software, and Autodesk, citing positive clinical trial developments, AI integration, recurring revenue strength, and robust quarterly earnings across healthcare, enterprise software, and insurance tech sectors.

Guidewire Software is experiencing a shortened sales cycle due to reduced migration costs, indicating improved efficiency in its customer acquisition process.

Guidewire Software (GWRE) has announced strong third-quarter financial results, which have reportedly boosted investor confidence in the company.

Guidewire Software is set to release its third-quarter earnings report for fiscal year 2026. Investors and analysts are anticipating the results to assess the company's financial health and future outlook.

The Parnassus Mid Cap Fund sold its shares in Fidelity National Information Services (FIS), citing reduced conviction in the company's long-term structural growth.

According to analysts, Guidewire Software, Inc. (GWRE) stock has the potential to more than double from its current position.